Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta

Journal of Veterinary Science

Volumn 6, Issue 1, 2005, Pages 1-5

  Koh, Phil Ok ^a   Won, Chung Kil ^a   Noh, Hae Sook ^b   Cho, Gyeong Jae ^b   Choi, Wan Sung ^b  

^a Gyeongsang National University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Human; PACAP; Placenta; Receptor

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MESSENGER RNA;

ARTICLE; AUTOREGULATION; CHORION VILLUS; CONTROLLED STUDY; FETUS GROWTH; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PLACENTA; PLACENTA LOCALIZATION; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STROMA CELL;

OVIS;

EID: 17144392232     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2005.6.1.1     Document Type: Article

References (33)

1. Angerer LM, Cox KH, Angerer RC. Demonstration of tissue-specific gene expression by in situ hybridization. Methods Enzymol 1987, 152, 649-661.
2. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 1991, 129, 2787-2789.
3. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept 1992, 37, 287-303.
4. Besson J, Malassine A, Ferre F. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase. Regul Pept 1987, 19, 197-207.
5. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998, 59, 1540-1548.
6. Correia-da-Silva G, Bell SC, Pringle JH, Teixeira N. Expression of mRNA encoding insulin-like growth factors I and II by uterine tissues and placenta during pregnancy in the rat. Mol Reprod Dev 1999, 53, 294-305.
7. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK, Renner U. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol 1999, 160, 483-490.
8. Gonzalez BJ, Basille M, Vaudry D, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. Neuroscience 1997, 78, 419-430.
9. Graf AH, Hutter W, Hacker GW, Steiner H, Anderson V, Staudach A, Dietze O. Localization and distribution of vasoactive neuropeptides in the human placenta. Placenta 1996, 17, 413-421.
10. Hashimoto H, Ishihara T, Shigemoto R, Mori K, Nagata S. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 1993, 11, 333-342.
11. Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki J, Seino S. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci USA 1994, 29, 2679-2683.
12. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992, 8, 811-819.
13. Koh PO, Kwak SD, Kim HJ, Roh G, Kim JH, Kang SS, Choi WS, Cho GJ. Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta. Mol Reprod Dev 2003, 64, 27-31.
14. Koh PO, Kwak SD, Kang SS, Cho GJ, Chun SY, Kwon HB, Choi WS. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary. Mol Reprod Dev 2000, 55, 379-386.
15. Kotani E, Usuki S, Kubo T. Rat corpus luteum expresses both PACAP and PACAP type IA receptor mRNAs. Peptides 1997, 18, 1453-1455.
16. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991, 88, 9267-9271.
17. Matsumoto H, Koyama C, Sawada T, Koike K, Hirota K, Miyake A, Arimura A, Inoue K. Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotropic peptide (pituitary adenylate cyclase-activating peptide), showing increasedadenosine 3́,5́-monophosphate and interleukin-6 secretion and cell proliferation. Endocrinology 1993, 133, 2150-2155.
18. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD,Coy DH. Isolation of a novel 38 residue hypothalamic peptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989, 164, 567-574.
19. Miyata A, Jiang L, Dahl RR, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990, 170, 643-648.
20. Moretti C, Mencacci C, Frajese GV, Cerilli M, Frajese G.. Growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in the reproductive system. Trends Endocrinol Metab 2002, 13, 428-435.
21. Ogilvie S, Buhi WC, Olson JA, Shiverick KT. Identification of a novel family of growth hormone-related proteins secreted by rat placenta. Endocrinology 1990, 126, 3271-3273.
22. Scaldaferri L, Arora K, Lee SH, Catt KJ, Moretti C. Expression of PACAP and its type-I receptor isoforms in the rat ovary. Mol Cell Endocrinol 1996, 25, 227-232.
23. Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Endocrinology 2000, 141, 1158-1167.
24. Sherwood NM, Krueckl SL, McRory JE. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000 21, 619-670.
25. Shioda S, Legradi G, Leung WC, Nakajo S, Nakaya K, Arimura A. Localization of pituitary adenylate cyclase-activating polypeptide and its messenger ribonucleic acid in the rat testis by light and electron microscopic immunocytochemistry and in situ hybridization. Endocrinology 1994, 135, 818-825.
26. Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K. Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996, 17, 111-121.
27. Shivers BD, Gorcs TJ, Gottschall PE, Arimura A. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 1991, 128, 3055-3065.
28. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993, 365, 170-175.
29. Srivastava RK, Gu Y, Ayloo S, Zilberstein M, Gibori G. Developmental expression and regulation of basic fibroblast growth factor and vascular endothelial growth factor in rat decidua and in a decidual cell line. J Mol Endocrinol 1998, 21, 355-362.
30. Steenstrup BR, Jorgensen JC, Alm P, Hannibal J, Junge J, Fahrenkrug J, Ottesen B. Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilator/effect in the human uteroplacental unit. Regul Pept 1996, 22, 197-204.
31. Tischler AS, Riseberg JC, Gray R. Mitogenic and antimitogenic effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in adult rat chromaffin cell cultures. Neurosci Lett 1995, 21, 135-138.
32. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmaki E. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997, 56, 489-494.
33. Wolf N, Krieglstein K. Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase activating polypeptide. Neurosci Lett 1995, 24, 207-210.